Rep. Doggett: Bicameral Effort to Stop Proposed Rule Undermining Long-Standing Tool to Restrain Price Gouging for Taxpayer-Funded Drugs
March 30, 2021
March 30, 2021
WASHINGTON, March 30 -- Rep. Lloyd Doggett, D-Texas, issued the following news release:
Over 35 bicameral members of Congress, led by U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways & Means Health Subcommittee, submitted a public comment opposing a Trump-era proposed rule to revoke the federal government's ability to protect taxpayer investments and reasonable prices for prescription drugs and other patented inventions. The 32 House members were joined by Se . . .
Over 35 bicameral members of Congress, led by U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways & Means Health Subcommittee, submitted a public comment opposing a Trump-era proposed rule to revoke the federal government's ability to protect taxpayer investments and reasonable prices for prescription drugs and other patented inventions. The 32 House members were joined by Se . . .